Back to Journals » Drug Design, Development and Therapy » Volume 10

Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod

Total article views   Abstract views HTML views PDF downloads Totals
11,999 Dovepress* 8,659 1,679+ 1,207 10,338
PubMed Central* 0 1,661 496 1,661
Totals 8,659 3,340 1,703 11,999
*Since 30 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
19 1 0 0 7 11

View citations on PubMed Central and Google Scholar